Cargando…
Caspase-4/11 exacerbates disease severity in SARS–CoV-2 infection by promoting inflammation and immunothrombosis
Severe acute respiratory syndrome coronavirus 2 (SARS–CoV-2) is a worldwide health concern, and new treatment strategies are needed. Targeting inflammatory innate immunity pathways holds therapeutic promise, but effective molecular targets remain elusive. Here, we show that human caspase-4 (CASP4) a...
Ejemplares similares
-
CFTR Modulators Restore Acidification of Autophago-Lysosomes and Bacterial Clearance in Cystic Fibrosis Macrophages
por: Badr, Asmaa, et al.
Publicado: (2022) -
Elevated Expression of MiR-17 in Microglia of Alzheimer’s Disease Patients Abrogates Autophagy-Mediated Amyloid-β Degradation
por: Estfanous, Shady, et al.
Publicado: (2021) -
Interferon‐induced transmembrane protein 3 (IFITM3) limits lethality of SARS‐CoV‐2 in mice
por: Kenney, Adam D, et al.
Publicado: (2023) -
A Novel Supplementation Approach to Enhance Host Response to Sublingual Vaccination
por: Rowe, John C., et al.
Publicado: (2019) -
Gasdermin D restricts Burkholderia cenocepacia infection in vitro and in vivo
por: Estfanous, Shady, et al.
Publicado: (2021)